{"data":{"id":256,"lang":"en","title":"Chinese Scientists Turn Single Stem Cell Into 14 Million Cancer-Killing NK Cells in Mass Production Breakthrough","summary":"Chinese Academy of Sciences turns one stem cell into 14 million cancer-fighting NK cells, slashing immunotherapy costs.","category":"science","category_label":"Science","published_at":"2026-02-19T01:01:37Z","updated_at":"2026-02-19T01:01:37Z","url":"https://techtools.cz/tools/news/article/256-chinese-scientists-turn-single-stem-cell-into-14-million-cancer-killing-nk","api_url":"https://techtools.cz/news-api/v1/articles/256?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/256.md?lang=en","image_url":"https://cff2.earth.com/uploads/2026/02/09120906/chinese-scientists-multiply-natural-killer-cancer-cells.jpg","word_count":194,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/02/260215225600.htm","domain":"sciencedaily.com"},{"url":"https://www.earth.com/news/chinese-scientists-create-scalable-method-for-cancer-fighting-cells/","domain":"earth.com"}],"translation":{"lang":"cs","id":235,"title":"Čínští vědci vyrobili z jedné kmenové buňky 14 milionů protinádorových NK buněk v průlomu masové výroby","url":"https://techtools.cz/tools/news/clanek/235-cinsti-vedci-vyrobili-z-jedne-kmenove-bunky-14-milionu-protinadorovych-nk-bunek","api_url":"https://techtools.cz/news-api/v1/articles/235?lang=cs"},"content":"Researchers at the Chinese Academy of Sciences have engineered a method to mass-produce natural killer (NK) cells from cord blood stem cells, potentially making cancer immunotherapy far cheaper and more accessible. Led by Prof. Wang Jinyong, the team took a single CD34+ stem cell from donated umbilical cord blood and expanded it through a three-stage process, generating up to 14 million tumor-killing NK cells — including 7.6 million CAR-equipped versions designed to target specific cancers.\n\nThe technique uses roughly 1/140,000 to 1/600,000 of the viral vector typically required for mature NK cell modification, dramatically cutting production costs. One-fifth of a typical cord blood unit could theoretically yield thousands to tens of thousands of treatment doses. In laboratory tests on leukemia models, the cells demonstrated powerful tumor-killing ability, and critically, zero T cells were found mixed in — removing a common safety concern.\n\nThe findings, published in Nature Biomedical Engineering on February 17, were funded by China's Ministry of Science and Technology and the National Natural Science Foundation of China. If validated in clinical trials, the approach could transform NK cell therapy from an expensive, small-batch treatment into a scalable off-the-shelf cancer weapon."}}